ClinicalTrials.gg
Sign In

Drug

AllogeneicNatural Killer Cells SAR445419 clinical trials

Also written SAR445419.

studies test it
3
open now
0
in phase 3
0
first study started
2023

How studies write it

Studies that test it under each name

Development codes

SAR445419
2
KDS-1001
1

Studies by the year they started

3 studies that test it; most in 2024 (2)

Studies that test AllogeneicNatural Killer Cells SAR445419, by start year
YearStudies
20231
20242

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
1

What it is tested for

Each study’s main condition, where its own words name it.

Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1

Who runs them

Industry 2 · Other 1

Sanofi (2) · Duke University (1)

Studies

Open first, then newest update. How each study uses AllogeneicNatural Killer Cells SAR445419 is read from its arms, and is right about nine times in ten.

Testing it · 3